Ceva Animal Health Announces New Leader for North American Market

Posted January 15, 2024

Lenexa-based Ceva Animal Health announced it has appointed its new senior vice president for North America who will lead development and activities in the United States and Canada.

Brad McCollum is now the senior vice president for North America for Ceva and brings more than 25 years of experience in pharmaceuticals and animal health. Lenexa is the company’s North American headquarters.

“Leveraging my in-depth knowledge of the market and customer needs in North America, I am eager to continue innovating and offering novel solutions for our customers,” he said.

Previously, McCollum served 11 years at Zoetis, culminating in his last role as Senior Vice President of Petcare for the U.S. Business. McCollum began his career in pharmaceuticals as associate director of operations at Pfizer.

McCollum succeeds 17-year Ceva veteran Jean-Charles Tissot, who has been overseeing this region since 2019. Tissot is now leading Ceva’s global autogenous vaccine activities, according to a release.

“We are determined to play in the top league in the pet market, and Brad McCollum’s appointment reinforces our commitment to innovation and efficiency to address the evolving needs of our customers,” executive vice president for global commercial operations, Andras Bolcskei said in the release.

Ceva’s global headquarters is in Libourne, France, and specializes in the development and production of pharmaceutical products and vaccines for companion animals, livestock, swine and poultry.